Decision-making in a phase II clinical trial: a new approach combining Bayesian and frequentist concepts
- 1 April 2005
- journal article
- research article
- Published by Wiley in Pharmaceutical Statistics
- Vol. 4 (2) , 119-128
- https://doi.org/10.1002/pst.164
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Sequential designs for phase III clinical trials incorporating treatment selectionStatistics in Medicine, 2003
- Seamlessly Expanding a Randomized Phase II Trial to Phase IIIBiometrics, 2002
- Combining different phases in the development of medical treatments within a single trialStatistics in Medicine, 1999
- Sample size determination for phase II clinical trials based on Bayesian decision theory.Published by JSTOR ,1998
- Semiparametric Efficiency and its Implication on the Design and Analysis of Group-Sequential StudiesJournal of the American Statistical Association, 1997
- Bayesian Approaches to Randomized TrialsJournal of the Royal Statistical Society Series A: Statistics in Society, 1994
- A Bayesian Approach to the Analysis of Data from Clinical TrialsJournal of the American Statistical Association, 1965